Answers are grounded in this paper and cite their sources.
Objective: To compare the clinical outcomes and visual quality of subjects undergoing cataract surgery with the implantation of two different models of diffractive trifocal intraocular lenses (IOL). Material and Methods: This was a prospective, parallel-group, randomized, comparative, single-masked clinical study. A total of 30 subjects, who were scheduled to undergo bilateral cataract surgery were randomly assigned to two groups: RayOne and PanOptix IOL. The outcome measures were corrected and uncorrected distance visual acuity (CDVA, UDVA) at 4 m, uncorrected intermediate visual acuity (UIVA) at 80 and 60 cm, distance-corrected intermediate visual acuity (DCIVA) at 60 and 80 cm, distance-corrected and uncorrected near visual acuity at 40 cm, and patients' satisfaction. Results: Each group comprised 30 eyes of 15 subjects. No statistically significant differences were determined between the groups in terms of CDVA, UDVA, distance-corrected near visual acuity, and uncorrected near visual acuity. The monocular UIVA values at 80 cm were 0.09±0.09 logMAR in the RayOne IOL group and 0.19±0.11 logMAR in the PanOptix IOL group (p=0.01). The UIVA values at 60 cm were better in the PanOptix IOL group (p=0.049,p=0.01, respectively), and the DCIVA at 80 cm were better in the RayOne IOL group (p=0.01,0.047, respectively). The RayOne IOL group had more bothersome halos and starbursts (p=0.026,p=0.01, respectively). Conclusion: Both IOLs provided a very good restoration of visual acuity. However, with the PanOptix IOL, the likelihood of subjects experiencing bothersome halos and starbursts was less. The RayOne IOL might be a better choice for subjects that require further intermediate vision.
No takes yet. Share an insight, caveat, or question.
Yaprak et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: